106 related articles for article (PubMed ID: 8806472)
41. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.
Yeh KY; Pulaski BA; Woods ML; McAdam AJ; Gaspari AA; Frelinger JG; Lord EM
Cell Immunol; 1995 Oct; 165(2):217-24. PubMed ID: 7553886
[TBL] [Abstract][Full Text] [Related]
42. Mouse B7-H3 induces antitumor immunity.
Sun X; Vale M; Leung E; Kanwar JR; Gupta R; Krissansen GW
Gene Ther; 2003 Sep; 10(20):1728-34. PubMed ID: 12939639
[TBL] [Abstract][Full Text] [Related]
43. Changes of immunological patterns of human cancer cells treated in vitro with a triazene compound.
D'Atri S; Ballerini P; Fuggetta MP; Faggioni A; Piazza A; Giuliani A
Immunopharmacol Immunotoxicol; 1989; 11(1):101-18. PubMed ID: 2547862
[TBL] [Abstract][Full Text] [Related]
44. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
[TBL] [Abstract][Full Text] [Related]
45. Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growth.
Yeh KY; Chen Z; Nasir A; Ohsuga Y; Takashima A; Lord EM; Gaspari AA
J Invest Dermatol; 1997 Dec; 109(6):728-33. PubMed ID: 9406812
[TBL] [Abstract][Full Text] [Related]
46. Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes.
Jung D; Jaeger E; Cayeux S; Blankenstein T; Hilmes C; Karbach J; Moebius U; Knuth A; Huber C; Seliger B
Hum Gene Ther; 1998 Jan; 9(1):53-62. PubMed ID: 9458242
[TBL] [Abstract][Full Text] [Related]
47. Increased sensitivity of tumor cells to immune defense cells following treatment with antineoplastic agents in vitro.
Ujiie T
Jpn J Exp Med; 1989 Feb; 59(1):17-26. PubMed ID: 2786965
[TBL] [Abstract][Full Text] [Related]
48. [Induction of antitumor immune response by NK-cell-sensitive target cells transfected by B7-1 gene].
Zhao X; Wei Y; Kariya Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Aug; 15(4):210-3. PubMed ID: 9691127
[TBL] [Abstract][Full Text] [Related]
49. In vitro immunization against human tumor cells with tumor cell fractions.
Sharma B
Cancer Res; 1977 Dec; 37(12):4660-8. PubMed ID: 72600
[TBL] [Abstract][Full Text] [Related]
50. Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent.
Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
Scand J Immunol; 1999 Sep; 50(3):242-9. PubMed ID: 10447932
[TBL] [Abstract][Full Text] [Related]
51. [Function of B7/CD28 in anti-myeloma immunoreaction through activating T cells].
Guo L; Zhang X; Qiu Y
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):235-8. PubMed ID: 11601210
[TBL] [Abstract][Full Text] [Related]
52. Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells.
Nakatsuka K; Sugiyama H; Nakagawa Y; Takahashi H
J Hepatol; 1999 Jun; 30(6):1119-29. PubMed ID: 10406192
[TBL] [Abstract][Full Text] [Related]
53. Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro.
Habicht A; Lindauer M; Galmbacher P; Rudy W; Gebert J; Schackert HK; Meuer SC; Moebius U
Eur J Cancer; 1995 Dec; 31A(13-14):2396-402. PubMed ID: 8652275
[TBL] [Abstract][Full Text] [Related]
54. Replication-deficient adenovirus-mediated transfer of B7-1 (CD80) cDNA induces anti-tumour immunity in isolated human lung cancer.
Iwakami SI; Setoguchi Y; Saijo Y; Azuma M; Fukuchi Y
Respirology; 2001 Jun; 6(2):135-44. PubMed ID: 11422893
[TBL] [Abstract][Full Text] [Related]
55. Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis.
Semino C; Semino A; Pietra G; Mingari MC; Barocci S; Venturini PL; Ragni N; Melioli G
Fertil Steril; 1995 Nov; 64(5):909-16. PubMed ID: 7589633
[TBL] [Abstract][Full Text] [Related]
56. Immunomodulation by pulmonary surfactant.
Catanzaro A; Richman P; Batcher S; Hallman M
J Lab Clin Med; 1988 Dec; 112(6):727-34. PubMed ID: 3193028
[TBL] [Abstract][Full Text] [Related]
57. B7-1(CD80)-transfected human glioma cells and interleukin-12 directly stimulate allogeneic CD8+ T cells.
Komata T; Tanaka R; Yamamoto K; Oda T; Ono K; Yoshida S; Takahashi M
J Immunother; 1997 Jul; 20(4):256-64. PubMed ID: 9220315
[TBL] [Abstract][Full Text] [Related]
58. Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells.
Stärck L; Scholz C; Blankenstein T; Dörken B; Daniel PT
Int J Cancer; 2005 Aug; 116(1):78-86. PubMed ID: 15756675
[TBL] [Abstract][Full Text] [Related]
59. Direct cytotoxicity mediated by allogeneic and isogeneic pig lymphocytes modified with fluorescein isothiocyanate.
Morilla A; Licence ST; Binns RM
Rev Latinoam Microbiol; 1991; 33(1):40-7. PubMed ID: 1670253
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical localization of B7 costimulating molecules and major histocompatibility complex class II antigen in pulmonary sarcoidosis.
Kaneko Y; Kuwano K; Kunitake R; Kawasaki M; Hagimoto N; Miyazaki H; Maeyama T; Tanaka T; Matsuba T; Hara N
Respiration; 1999; 66(4):343-8. PubMed ID: 10461083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
